Immunomodulation Effect of Convalescent Plasma Therapy in Severe - Critical COVID-19 Patients
Description
CONCLUSION: No correlation between the increase in s-RBD IgG levels and changes in IL-4 and IL-6 levels. Changes in s-RBD IgG, IL-4, and IL-6 levels are not associated with mortality in severe-critical COVID-19 degree post CPT recipients.
